Hemodynamic effects of parathyroid hormone-related peptide-(1-34) in humans

Journal of Clinical Endocrinology and Metabolism

Volumn 82, Issue 8, 1997, Pages 2548-2551

  Wolzt, Michael ^a,b   Schmetterer, Leopold ^a   Dorner, Guido ^a   Zelger, Georg ^a   Entlicher, Jesusa ^a   Kapiotis, Stylianos ^a   Eichler, Hans Georg ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

PARATHYROID HORMONE RELATED PROTEIN;

ADULT; ARTICLE; CARDIOVASCULAR SYSTEM; CHRONOTROPISM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; HEMODYNAMICS; HUMAN; HUMAN EXPERIMENT; INOTROPISM; KIDNEY PLASMA FLOW; MALE; PHARMACODYNAMICS; PRIORITY JOURNAL; PULSE RATE; RANDOMIZED CONTROLLED TRIAL; VEIN DILATATION;

ADULT; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CROSS-OVER STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; HEMODYNAMIC PROCESSES; HUMANS; KIDNEY; MALE; PARATHYROID HORMONE-RELATED PROTEIN; PEPTIDE FRAGMENTS; PHENYLEPHRINE; PLACEBOS; PROTEINS; PULSE; RENAL CIRCULATION; VASODILATION;

EID: 0030851477     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.82.8.2548     Document Type: Article

References (30)

1. Martin TJ, Allan EH, Caple IW, et al. 1989 Parathyroid hormone-related protein: isolation, molecular cloning, and mechanism of action. Recent Prog Horm Res. 45:467-502.
2. Bui TD, Shallal A, Malik AN, et al. 1993 Parathyroid hormone related peptide gene expression in human fetal and adult heart. Cardiovasc Res. 27:1204-1208.
3. Burton DW, Brandt DW, Deftos LJ. 1994 Parathyroid hormone-related protein in the cardiovascular system. Endocrinology. 135:253-261.
4. Hongo T, Kupfer J, Enomoto H, et al. 1991 Abundant expression of parathyroid hormone-related protein in primary rat aortic smooth muscle cells accompanies serum-induced proliferation. J Clin Invest. 88:1841-1847.
5. Noda M, Takuwa Y, Katoh T, Kurokawa K. 1996 Mechanical force regulation of vascular parathyroid hormone-related peptide expression. Kidney Int. 55(Suppl):S154-S155.
6. Noda M, Katoh T, Takuwa N, Kumada M, Kurokawa K, Takuwa Y. 1994 Synergistic stimulation of parathyroid hormone-related peptide gene expression by mechanical stretch and angiotensin II in rat aortic smooth muscle cells. J Biol Chem. 269:17911-17917.
7. Nickols GA, Nana AD, Nickols MA, DiPette DJ, Asimakis GK. 1989 Hypotension and cardiac stimulation due to the parathyroid hormone-related protein, humoral hypercalcemia of malignancy factor. Endocrinology. 125:834-841.
8. Roca-Cusachs A, DiPette DJ, Nickols GA. 1991 Regional and systemic hemodynamic effects of parathyroid hormone-related protein: preservation of cardiac function and coronary and renal flow with reduced blood pressure. J Pharmacol Exp Ther. 256:110-118.
9. Shan J, Pang PK, Lin HC, Yang MC. 1994 Cardiovascular effects of human parathyroid hormone and parathyroid hormone-related peptide. J Cardiovasc Pharmacol. 23(Suppl 2):S38-S41.
10. DiPette DJ, Christenson W, Nickols MA, Nickols GA. 1992 Cardiovascular responsiveness to parathyroid hormone (PTH) and PTH-related protein in genetic hypertension. Endocrinology. 130:2045-2051.
11. Massfelder T, Parekh N, Endlich K, Saussine C, Steinhausen M, Helwig JJ. 1996 Effect of intrarenally infused parathyroid hormone-related protein on renal blood flow and glomerular filtration rate in the anaesthetized rat. Br J Pharmacol. 118:1995-2000.
12. Everhart-Caye M, Inzucchi SE, Guinness Henry J, Mitnick MA, Stewart AF. 1996 Parathyroid hormone (PTH)-related protein-(1-36) is equipotent to PTH(1-34) in humans. J Clin Endocrinol Metab. 81:199-208.
13. Philbrick WM, Wysolmerski JJ, Galbraith S, et al. 1996 Defining the roles of parathyroid hormone-related protein in normal physiology. Physiol Rev. 76:127-173.
14. Aellig WH. 1994 Clinical pharmacology, physiology and pathophysiology of superficial veins-1. Br J Clin Pharmacol. 38:181-196.
15. Aellig WH. 1994 Clinical pharmacology, physiology and pathophysiology of superficial veins-2. Br J Clin Pharmacol. 38:289-305.
16. McEwan JR, Benjamin N, Larkin S, Fuller RW, Dollery CT, MacIntyre I. 1988 Vasodilatation by calcitonin gene-related peptide and by substance P: a comparison of their effects on resistance and capacitance vessels of human forearms. Circulation. 77:1072-1080.
17. Blöchl-Daum B, Korn A, Wolzt M, Schmidt E, Eichler HG. 1991 In vivo studies on alpha-adrenergic receptor subtypes in human veins. Naunyn Schmiedebergs Arch Pharmacol. 344:302-307.
18. Schnurr E, Lahme W, Kuppers H. 1980 Measurement of renal clearance of inulin and PAH in the steady state without urine collection. Clin Nephrol. 13:26-29.
19. Prescott LF, Freestone S, McAuslane JA. 1993 The concentration-dependent disposition of intravenous p-aminohippurate in subjects with normal and impaired renal function. Br J Clin Pharmacol. 35:20-29.
20. Wolzt M, Schmetterer L, Ferber W, et al. 1997 Effect of nitric oxide synthase inhibition on renal hemodynamics in humans: reversal by L-arginine. Am J Physiol. 272:F178-F182.
21. Weissler AM, Harris WS, Schoenfeld CD. 1968 Systolic time intervals in heart failure in man. Circulation. 37:149-159.
22. de Mey C, Belz GG, Nixdorf U, et al. 1992 Relative sensitivity of four noninvasive methods in assessing systolic cardiovascular effects of isoproterenol in healthy volunteers. Clin Pharmacol Ther. 52:609-619.
23. Wolzt M, Schmetterer L, Rheinberger A, et al. 1995 Comparison of noninvasive methods for the assessment of haemodynamic drug effects in healthy male and female volunteers: sex differences in cardiovascular responsiveness. Br J Clin Pharmacol. 39:347-359.
24. Waugh WH, Beall PT. 1974 Simplified measurement of p-aminohippurate and other arylamines in plasma and urine. Kidney Int. 5:429-436.
25. Fraher LJ, Klein K, Marier R, et al. 1995 Comparison of the pharmacokinetics of parenteral parathyroid hormone-(1-34) [PTH-(1-34)] and PTH-related peptide-(1-34) in healthy young humans. J Clin Endocrinol Metab. 80:60-64.
26. Ogino K, Burkhoff D, Bilezikian JP. 1995 The hemodynamic basis for the cardiac effects of parathyroid hormone (PTH) and PTH-related protein. Endocrinology. 136:3024-3030.
27. Endlich K, Massfelder T, Helwig JJ, Steinhausen M. 1995 Vascular effects of parathyroid hormone and parathyroid hormone-related protein in the split hydronephrotic rat kidney. J Physiol (Lond). 483:481-490.
28. Massfelder T, Stewart AF, Endlich K, Soifer N, Judes C, Helwig JJ. 1996 Parathyroid hormone-related protein detection and interaction with NO and cyclic AMP in the renovascular system. Kidney Int. 50:1591-1603.
29. Saussine C, Massfelder T, Parnin F, Judes C, Simeoni U, Helwig JJ. 1993 Renin stimulating properties of parathyroid hormone-related peptide in the isolated perfused rat kidney. Kidney Int. 44:764-773.
30. Fraher LJ, Hodsman AB, Jonas K, et al. 1992 A comparison of the in vivo biochemical responses to exogenous parathyroid hormone-(1-34) [PTH-(1-34)] and PTH-related peptide-(1-34) in man. J Clin Endocrinol Metab 75:417-423.